SPAG9 May Be a Potential Prognostic Marker of Endometrial Hyperplasia and Grade 1 Endometrioid Adenocarcinoma Treated with Progestin. [electronic resource]
Producer: 20170411Description: 267-74 p. digitalISSN:- 1423-002X
- Adaptor Proteins, Signal Transducing -- analysis
- Adult
- Antineoplastic Agents, Hormonal -- therapeutic use
- Biomarkers, Tumor -- analysis
- Blotting, Western
- Carcinoma, Endometrioid -- diagnosis
- Cell Line, Tumor
- Early Detection of Cancer -- methods
- Endometrial Hyperplasia -- diagnosis
- Endometrial Neoplasms -- diagnosis
- Female
- Humans
- Immunohistochemistry
- Medroxyprogesterone Acetate -- therapeutic use
- Prognosis
- Real-Time Polymerase Chain Reaction
- Reverse Transcriptase Polymerase Chain Reaction
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.